Global Transdermal Preparation Supply, Demand and Key Producers, 2026-2032
The global Transdermal Preparation market size is expected to reach $ 55706 million by 2032, rising at a market growth of 3.1% CAGR during the forecast period (2026-2032).
Transdermal preparations refer to a dosage form that delivers drugs into the systemic circulation or local tissues through the skin as a route of administration in the form of patches, gels, plasters, microneedles or hot melt adhesive systems, achieving sustained release, stable blood drug concentration or local targeted therapy. They are widely used in pain relief, hormone replacement, cardiovascular diseases, smoking cessation and neurological disorders treatment. The core advantages are non-invasive administration and improved patient compliance. The global sales volume is expected to reach approximately 1.92 billion units in 2025, with an average unit price of about 22.8 US dollars and a capacity utilization rate of around 87%. The upstream mainly consists of raw material drug enterprises, suppliers of polymer materials and pressure-sensitive adhesives, transdermal enhancers and functional excipients. The midstream includes formulation development and patch manufacturing enterprises. The downstream comprises pharmaceutical companies, hospitals, chain pharmacies and home medical channels. The industry's gross profit margin is typically between 55% and 75%, with high-end microneedles and long-acting controlled-release products exceeding 75%. In the product cost structure, raw materials and functional excipients account for about 38% to 45%, polymer substrates and pressure-sensitive adhesives about 22%, process development and R&D costs about 15%, production and quality control about 10%, and packaging, distribution channels and logistics about 8% to 12%.
The transdermal preparation industry is currently at a critical stage of upgrading from traditional sustained-release patches to high-end intelligent delivery systems. Its core growth drivers come from the continuous expansion of long-term medication needs for chronic diseases and the healthcare system's increasing preference for non-invasive treatment solutions. Structurally, the low-end mature patch market is growing steadily, while microneedles, intelligent controlled-release, and composite delivery systems are becoming the main growth engines. In the future, competition will shift from single formulations to integrated solutions combining drugs and delivery systems, with significant increases in technical barriers. As the integration of materials science, bioengineering, and smart medical technology deepens, the role of transdermal preparations in precision medicine will be further enhanced. At the same time, pharmaceutical companies are accelerating the development of long-acting formulations and differentiated drug delivery pathways to improve lifecycle management capabilities. Overall, the industry still has strong potential for technological advancement and structural upgrading, with a clear long-term growth logic, and is expected to continue expanding under the backdrop of global aging and chronic disease management demands.
This report studies the global Transdermal Preparation production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transdermal Preparation and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Preparation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transdermal Preparation total production and demand, 2021-2032, (K Units)
Global Transdermal Preparation total production value, 2021-2032, (USD Million)
Global Transdermal Preparation production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Transdermal Preparation consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Transdermal Preparation domestic production, consumption, key domestic manufacturers and share
Global Transdermal Preparation production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Transdermal Preparation production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Transdermal Preparation production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Transdermal Preparation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M (US), AdhexPharma (FR), Bayer AG (DE), Boehringer Ingelheim (DE), Corium (US), Endo International (IE), GlaxoSmithKline (GSK) (GB), Gr?nenthal Group (DE), Henkel (DE), Hisamitsu Pharmaceutical (JP), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Preparation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transdermal Preparation Market, By Region:
1. How big is the global Transdermal Preparation market?
2. What is the demand of the global Transdermal Preparation market?
3. What is the year over year growth of the global Transdermal Preparation market?
4. What is the production and production value of the global Transdermal Preparation market?
5. Who are the key producers in the global Transdermal Preparation market?
6. What are the growth factors driving the market demand?
Transdermal preparations refer to a dosage form that delivers drugs into the systemic circulation or local tissues through the skin as a route of administration in the form of patches, gels, plasters, microneedles or hot melt adhesive systems, achieving sustained release, stable blood drug concentration or local targeted therapy. They are widely used in pain relief, hormone replacement, cardiovascular diseases, smoking cessation and neurological disorders treatment. The core advantages are non-invasive administration and improved patient compliance. The global sales volume is expected to reach approximately 1.92 billion units in 2025, with an average unit price of about 22.8 US dollars and a capacity utilization rate of around 87%. The upstream mainly consists of raw material drug enterprises, suppliers of polymer materials and pressure-sensitive adhesives, transdermal enhancers and functional excipients. The midstream includes formulation development and patch manufacturing enterprises. The downstream comprises pharmaceutical companies, hospitals, chain pharmacies and home medical channels. The industry's gross profit margin is typically between 55% and 75%, with high-end microneedles and long-acting controlled-release products exceeding 75%. In the product cost structure, raw materials and functional excipients account for about 38% to 45%, polymer substrates and pressure-sensitive adhesives about 22%, process development and R&D costs about 15%, production and quality control about 10%, and packaging, distribution channels and logistics about 8% to 12%.
The transdermal preparation industry is currently at a critical stage of upgrading from traditional sustained-release patches to high-end intelligent delivery systems. Its core growth drivers come from the continuous expansion of long-term medication needs for chronic diseases and the healthcare system's increasing preference for non-invasive treatment solutions. Structurally, the low-end mature patch market is growing steadily, while microneedles, intelligent controlled-release, and composite delivery systems are becoming the main growth engines. In the future, competition will shift from single formulations to integrated solutions combining drugs and delivery systems, with significant increases in technical barriers. As the integration of materials science, bioengineering, and smart medical technology deepens, the role of transdermal preparations in precision medicine will be further enhanced. At the same time, pharmaceutical companies are accelerating the development of long-acting formulations and differentiated drug delivery pathways to improve lifecycle management capabilities. Overall, the industry still has strong potential for technological advancement and structural upgrading, with a clear long-term growth logic, and is expected to continue expanding under the backdrop of global aging and chronic disease management demands.
This report studies the global Transdermal Preparation production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transdermal Preparation and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Preparation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transdermal Preparation total production and demand, 2021-2032, (K Units)
Global Transdermal Preparation total production value, 2021-2032, (USD Million)
Global Transdermal Preparation production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Transdermal Preparation consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Transdermal Preparation domestic production, consumption, key domestic manufacturers and share
Global Transdermal Preparation production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Transdermal Preparation production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Transdermal Preparation production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Transdermal Preparation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M (US), AdhexPharma (FR), Bayer AG (DE), Boehringer Ingelheim (DE), Corium (US), Endo International (IE), GlaxoSmithKline (GSK) (GB), Gr?nenthal Group (DE), Henkel (DE), Hisamitsu Pharmaceutical (JP), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Preparation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transdermal Preparation Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Injectable Preparations
- Non Injectable Preparations
- Patch
- Cataplasm Hydrogel Patch
- Hot Melt Adhesive Patch
- Other
- Hospital
- Clinic
- Other
- 3M (US)
- AdhexPharma (FR)
- Bayer AG (DE)
- Boehringer Ingelheim (DE)
- Corium (US)
- Endo International (IE)
- GlaxoSmithKline (GSK) (GB)
- Gr?nenthal Group (DE)
- Henkel (DE)
- Hisamitsu Pharmaceutical (JP)
- IBSA Group (CH)
- Johnson & Johnson (US)
- Luye Pharma Group (HK)
- LTS Lohmann Therapie-Systeme AG (DE)
- Mitsubishi Tanabe Pharma Corporation (JP)
- Mundipharma (GB)
- Mylan (Viatris) (US)
- Nitto Denko Corporation (JP)
- Noven Pharmaceuticals (US)
- Novartis AG (CH)
- Perrigo Company plc (IE)
- ProSolus, Inc. (US)
- Purdue Pharma L.P. (US)
- Scilex Pharmaceuticals (US)
- Sino-American Tianjin Squibb (CN)
- SOLA Pharmaceuticals (US)
- Sun Pharmaceutical Industries Ltd. (IN)
- Tapemark (US)
- Teikoku Seiyaku Co., Ltd. (JP)
- Teva Pharmaceutical Industries Ltd. (IL)
- UCB Pharma (BE)
- Upsher-Smith Laboratories (US)
- Henan Lingrui Pharmaceutical Co., Ltd. (CN)
- Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN)
1. How big is the global Transdermal Preparation market?
2. What is the demand of the global Transdermal Preparation market?
3. What is the year over year growth of the global Transdermal Preparation market?
4. What is the production and production value of the global Transdermal Preparation market?
5. Who are the key producers in the global Transdermal Preparation market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Transdermal Preparation Introduction
1.2 World Transdermal Preparation Supply & Forecast
1.2.1 World Transdermal Preparation Production Value (2021 & 2025 & 2032)
1.2.2 World Transdermal Preparation Production (2021-2032)
1.2.3 World Transdermal Preparation Pricing Trends (2021-2032)
1.3 World Transdermal Preparation Production by Region (Based on Production Site)
1.3.1 World Transdermal Preparation Production Value by Region (2021-2032)
1.3.2 World Transdermal Preparation Production by Region (2021-2032)
1.3.3 World Transdermal Preparation Average Price by Region (2021-2032)
1.3.4 North America Transdermal Preparation Production (2021-2032)
1.3.5 Europe Transdermal Preparation Production (2021-2032)
1.3.6 China Transdermal Preparation Production (2021-2032)
1.3.7 Japan Transdermal Preparation Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transdermal Preparation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transdermal Preparation Major Market Trends
2 DEMAND SUMMARY
2.1 World Transdermal Preparation Demand (2021-2032)
2.2 World Transdermal Preparation Consumption by Region
2.2.1 World Transdermal Preparation Consumption by Region (2021-2026)
2.2.2 World Transdermal Preparation Consumption Forecast by Region (2027-2032)
2.3 United States Transdermal Preparation Consumption (2021-2032)
2.4 China Transdermal Preparation Consumption (2021-2032)
2.5 Europe Transdermal Preparation Consumption (2021-2032)
2.6 Japan Transdermal Preparation Consumption (2021-2032)
2.7 South Korea Transdermal Preparation Consumption (2021-2032)
2.8 ASEAN Transdermal Preparation Consumption (2021-2032)
2.9 India Transdermal Preparation Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transdermal Preparation Production Value by Manufacturer (2021-2026)
3.2 World Transdermal Preparation Production by Manufacturer (2021-2026)
3.3 World Transdermal Preparation Average Price by Manufacturer (2021-2026)
3.4 Transdermal Preparation Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transdermal Preparation Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transdermal Preparation in 2025
3.5.3 Global Concentration Ratios (CR8) for Transdermal Preparation in 2025
3.6 Transdermal Preparation Market: Overall Company Footprint Analysis
3.6.1 Transdermal Preparation Market: Region Footprint
3.6.2 Transdermal Preparation Market: Company Product Type Footprint
3.6.3 Transdermal Preparation Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transdermal Preparation Production Value Comparison
4.1.1 United States VS China: Transdermal Preparation Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Transdermal Preparation Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Transdermal Preparation Production Comparison
4.2.1 United States VS China: Transdermal Preparation Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transdermal Preparation Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Transdermal Preparation Consumption Comparison
4.3.1 United States VS China: Transdermal Preparation Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Transdermal Preparation Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Transdermal Preparation Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Transdermal Preparation Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.4.3 United States Based Manufacturers Transdermal Preparation Production (2021-2026)
4.5 China Based Transdermal Preparation Manufacturers and Market Share
4.5.1 China Based Transdermal Preparation Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.5.3 China Based Manufacturers Transdermal Preparation Production (2021-2026)
4.6 Rest of World Based Transdermal Preparation Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Transdermal Preparation Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Transdermal Preparation Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transdermal Preparation Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Injectable Preparations
5.2.2 Non Injectable Preparations
5.3 Market Segment by Type
5.3.1 World Transdermal Preparation Production by Type (2021-2032)
5.3.2 World Transdermal Preparation Production Value by Type (2021-2032)
5.3.3 World Transdermal Preparation Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Transdermal Preparation Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Patch
6.2.2 Cataplasm Hydrogel Patch
6.2.3 Hot Melt Adhesive Patch
6.2.4 Other
6.3 Market Segment by Dosage Form
6.3.1 World Transdermal Preparation Production by Dosage Form (2021-2032)
6.3.2 World Transdermal Preparation Production Value by Dosage Form (2021-2032)
6.3.3 World Transdermal Preparation Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Transdermal Preparation Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Other
7.3 Market Segment by Application
7.3.1 World Transdermal Preparation Production by Application (2021-2032)
7.3.2 World Transdermal Preparation Production Value by Application (2021-2032)
7.3.3 World Transdermal Preparation Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 3M (US)
8.1.1 3M (US) Details
8.1.2 3M (US) Major Business
8.1.3 3M (US) Transdermal Preparation Product and Services
8.1.4 3M (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 3M (US) Recent Developments/Updates
8.1.6 3M (US) Competitive Strengths & Weaknesses
8.2 AdhexPharma (FR)
8.2.1 AdhexPharma (FR) Details
8.2.2 AdhexPharma (FR) Major Business
8.2.3 AdhexPharma (FR) Transdermal Preparation Product and Services
8.2.4 AdhexPharma (FR) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 AdhexPharma (FR) Recent Developments/Updates
8.2.6 AdhexPharma (FR) Competitive Strengths & Weaknesses
8.3 Bayer AG (DE)
8.3.1 Bayer AG (DE) Details
8.3.2 Bayer AG (DE) Major Business
8.3.3 Bayer AG (DE) Transdermal Preparation Product and Services
8.3.4 Bayer AG (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Bayer AG (DE) Recent Developments/Updates
8.3.6 Bayer AG (DE) Competitive Strengths & Weaknesses
8.4 Boehringer Ingelheim (DE)
8.4.1 Boehringer Ingelheim (DE) Details
8.4.2 Boehringer Ingelheim (DE) Major Business
8.4.3 Boehringer Ingelheim (DE) Transdermal Preparation Product and Services
8.4.4 Boehringer Ingelheim (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Boehringer Ingelheim (DE) Recent Developments/Updates
8.4.6 Boehringer Ingelheim (DE) Competitive Strengths & Weaknesses
8.5 Corium (US)
8.5.1 Corium (US) Details
8.5.2 Corium (US) Major Business
8.5.3 Corium (US) Transdermal Preparation Product and Services
8.5.4 Corium (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Corium (US) Recent Developments/Updates
8.5.6 Corium (US) Competitive Strengths & Weaknesses
8.6 Endo International (IE)
8.6.1 Endo International (IE) Details
8.6.2 Endo International (IE) Major Business
8.6.3 Endo International (IE) Transdermal Preparation Product and Services
8.6.4 Endo International (IE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Endo International (IE) Recent Developments/Updates
8.6.6 Endo International (IE) Competitive Strengths & Weaknesses
8.7 GlaxoSmithKline (GSK) (GB)
8.7.1 GlaxoSmithKline (GSK) (GB) Details
8.7.2 GlaxoSmithKline (GSK) (GB) Major Business
8.7.3 GlaxoSmithKline (GSK) (GB) Transdermal Preparation Product and Services
8.7.4 GlaxoSmithKline (GSK) (GB) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 GlaxoSmithKline (GSK) (GB) Recent Developments/Updates
8.7.6 GlaxoSmithKline (GSK) (GB) Competitive Strengths & Weaknesses
8.8 Gr?nenthal Group (DE)
8.8.1 Gr?nenthal Group (DE) Details
8.8.2 Gr?nenthal Group (DE) Major Business
8.8.3 Gr?nenthal Group (DE) Transdermal Preparation Product and Services
8.8.4 Gr?nenthal Group (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Gr?nenthal Group (DE) Recent Developments/Updates
8.8.6 Gr?nenthal Group (DE) Competitive Strengths & Weaknesses
8.9 Henkel (DE)
8.9.1 Henkel (DE) Details
8.9.2 Henkel (DE) Major Business
8.9.3 Henkel (DE) Transdermal Preparation Product and Services
8.9.4 Henkel (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Henkel (DE) Recent Developments/Updates
8.9.6 Henkel (DE) Competitive Strengths & Weaknesses
8.10 Hisamitsu Pharmaceutical (JP)
8.10.1 Hisamitsu Pharmaceutical (JP) Details
8.10.2 Hisamitsu Pharmaceutical (JP) Major Business
8.10.3 Hisamitsu Pharmaceutical (JP) Transdermal Preparation Product and Services
8.10.4 Hisamitsu Pharmaceutical (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Hisamitsu Pharmaceutical (JP) Recent Developments/Updates
8.10.6 Hisamitsu Pharmaceutical (JP) Competitive Strengths & Weaknesses
8.11 IBSA Group (CH)
8.11.1 IBSA Group (CH) Details
8.11.2 IBSA Group (CH) Major Business
8.11.3 IBSA Group (CH) Transdermal Preparation Product and Services
8.11.4 IBSA Group (CH) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 IBSA Group (CH) Recent Developments/Updates
8.11.6 IBSA Group (CH) Competitive Strengths & Weaknesses
8.12 Johnson & Johnson (US)
8.12.1 Johnson & Johnson (US) Details
8.12.2 Johnson & Johnson (US) Major Business
8.12.3 Johnson & Johnson (US) Transdermal Preparation Product and Services
8.12.4 Johnson & Johnson (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Johnson & Johnson (US) Recent Developments/Updates
8.12.6 Johnson & Johnson (US) Competitive Strengths & Weaknesses
8.13 Luye Pharma Group (HK)
8.13.1 Luye Pharma Group (HK) Details
8.13.2 Luye Pharma Group (HK) Major Business
8.13.3 Luye Pharma Group (HK) Transdermal Preparation Product and Services
8.13.4 Luye Pharma Group (HK) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Luye Pharma Group (HK) Recent Developments/Updates
8.13.6 Luye Pharma Group (HK) Competitive Strengths & Weaknesses
8.14 LTS Lohmann Therapie-Systeme AG (DE)
8.14.1 LTS Lohmann Therapie-Systeme AG (DE) Details
8.14.2 LTS Lohmann Therapie-Systeme AG (DE) Major Business
8.14.3 LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Product and Services
8.14.4 LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 LTS Lohmann Therapie-Systeme AG (DE) Recent Developments/Updates
8.14.6 LTS Lohmann Therapie-Systeme AG (DE) Competitive Strengths & Weaknesses
8.15 Mitsubishi Tanabe Pharma Corporation (JP)
8.15.1 Mitsubishi Tanabe Pharma Corporation (JP) Details
8.15.2 Mitsubishi Tanabe Pharma Corporation (JP) Major Business
8.15.3 Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Product and Services
8.15.4 Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Mitsubishi Tanabe Pharma Corporation (JP) Recent Developments/Updates
8.15.6 Mitsubishi Tanabe Pharma Corporation (JP) Competitive Strengths & Weaknesses
8.16 Mundipharma (GB)
8.16.1 Mundipharma (GB) Details
8.16.2 Mundipharma (GB) Major Business
8.16.3 Mundipharma (GB) Transdermal Preparation Product and Services
8.16.4 Mundipharma (GB) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Mundipharma (GB) Recent Developments/Updates
8.16.6 Mundipharma (GB) Competitive Strengths & Weaknesses
8.17 Mylan (Viatris) (US)
8.17.1 Mylan (Viatris) (US) Details
8.17.2 Mylan (Viatris) (US) Major Business
8.17.3 Mylan (Viatris) (US) Transdermal Preparation Product and Services
8.17.4 Mylan (Viatris) (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Mylan (Viatris) (US) Recent Developments/Updates
8.17.6 Mylan (Viatris) (US) Competitive Strengths & Weaknesses
8.18 Nitto Denko Corporation (JP)
8.18.1 Nitto Denko Corporation (JP) Details
8.18.2 Nitto Denko Corporation (JP) Major Business
8.18.3 Nitto Denko Corporation (JP) Transdermal Preparation Product and Services
8.18.4 Nitto Denko Corporation (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 Nitto Denko Corporation (JP) Recent Developments/Updates
8.18.6 Nitto Denko Corporation (JP) Competitive Strengths & Weaknesses
8.19 Noven Pharmaceuticals (US)
8.19.1 Noven Pharmaceuticals (US) Details
8.19.2 Noven Pharmaceuticals (US) Major Business
8.19.3 Noven Pharmaceuticals (US) Transdermal Preparation Product and Services
8.19.4 Noven Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.19.5 Noven Pharmaceuticals (US) Recent Developments/Updates
8.19.6 Noven Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.20 Novartis AG (CH)
8.20.1 Novartis AG (CH) Details
8.20.2 Novartis AG (CH) Major Business
8.20.3 Novartis AG (CH) Transdermal Preparation Product and Services
8.20.4 Novartis AG (CH) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.20.5 Novartis AG (CH) Recent Developments/Updates
8.20.6 Novartis AG (CH) Competitive Strengths & Weaknesses
8.21 Perrigo Company plc (IE)
8.21.1 Perrigo Company plc (IE) Details
8.21.2 Perrigo Company plc (IE) Major Business
8.21.3 Perrigo Company plc (IE) Transdermal Preparation Product and Services
8.21.4 Perrigo Company plc (IE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.21.5 Perrigo Company plc (IE) Recent Developments/Updates
8.21.6 Perrigo Company plc (IE) Competitive Strengths & Weaknesses
8.22 ProSolus, Inc. (US)
8.22.1 ProSolus, Inc. (US) Details
8.22.2 ProSolus, Inc. (US) Major Business
8.22.3 ProSolus, Inc. (US) Transdermal Preparation Product and Services
8.22.4 ProSolus, Inc. (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.22.5 ProSolus, Inc. (US) Recent Developments/Updates
8.22.6 ProSolus, Inc. (US) Competitive Strengths & Weaknesses
8.23 Purdue Pharma L.P. (US)
8.23.1 Purdue Pharma L.P. (US) Details
8.23.2 Purdue Pharma L.P. (US) Major Business
8.23.3 Purdue Pharma L.P. (US) Transdermal Preparation Product and Services
8.23.4 Purdue Pharma L.P. (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.23.5 Purdue Pharma L.P. (US) Recent Developments/Updates
8.23.6 Purdue Pharma L.P. (US) Competitive Strengths & Weaknesses
8.24 Scilex Pharmaceuticals (US)
8.24.1 Scilex Pharmaceuticals (US) Details
8.24.2 Scilex Pharmaceuticals (US) Major Business
8.24.3 Scilex Pharmaceuticals (US) Transdermal Preparation Product and Services
8.24.4 Scilex Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.24.5 Scilex Pharmaceuticals (US) Recent Developments/Updates
8.24.6 Scilex Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.25 Sino-American Tianjin Squibb (CN)
8.25.1 Sino-American Tianjin Squibb (CN) Details
8.25.2 Sino-American Tianjin Squibb (CN) Major Business
8.25.3 Sino-American Tianjin Squibb (CN) Transdermal Preparation Product and Services
8.25.4 Sino-American Tianjin Squibb (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.25.5 Sino-American Tianjin Squibb (CN) Recent Developments/Updates
8.25.6 Sino-American Tianjin Squibb (CN) Competitive Strengths & Weaknesses
8.26 SOLA Pharmaceuticals (US)
8.26.1 SOLA Pharmaceuticals (US) Details
8.26.2 SOLA Pharmaceuticals (US) Major Business
8.26.3 SOLA Pharmaceuticals (US) Transdermal Preparation Product and Services
8.26.4 SOLA Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.26.5 SOLA Pharmaceuticals (US) Recent Developments/Updates
8.26.6 SOLA Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.27 Sun Pharmaceutical Industries Ltd. (IN)
8.27.1 Sun Pharmaceutical Industries Ltd. (IN) Details
8.27.2 Sun Pharmaceutical Industries Ltd. (IN) Major Business
8.27.3 Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Product and Services
8.27.4 Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.27.5 Sun Pharmaceutical Industries Ltd. (IN) Recent Developments/Updates
8.27.6 Sun Pharmaceutical Industries Ltd. (IN) Competitive Strengths & Weaknesses
8.28 Tapemark (US)
8.28.1 Tapemark (US) Details
8.28.2 Tapemark (US) Major Business
8.28.3 Tapemark (US) Transdermal Preparation Product and Services
8.28.4 Tapemark (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.28.5 Tapemark (US) Recent Developments/Updates
8.28.6 Tapemark (US) Competitive Strengths & Weaknesses
8.29 Teikoku Seiyaku Co., Ltd. (JP)
8.29.1 Teikoku Seiyaku Co., Ltd. (JP) Details
8.29.2 Teikoku Seiyaku Co., Ltd. (JP) Major Business
8.29.3 Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Product and Services
8.29.4 Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.29.5 Teikoku Seiyaku Co., Ltd. (JP) Recent Developments/Updates
8.29.6 Teikoku Seiyaku Co., Ltd. (JP) Competitive Strengths & Weaknesses
8.30 Teva Pharmaceutical Industries Ltd. (IL)
8.30.1 Teva Pharmaceutical Industries Ltd. (IL) Details
8.30.2 Teva Pharmaceutical Industries Ltd. (IL) Major Business
8.30.3 Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Product and Services
8.30.4 Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.30.5 Teva Pharmaceutical Industries Ltd. (IL) Recent Developments/Updates
8.30.6 Teva Pharmaceutical Industries Ltd. (IL) Competitive Strengths & Weaknesses
8.31 UCB Pharma (BE)
8.31.1 UCB Pharma (BE) Details
8.31.2 UCB Pharma (BE) Major Business
8.31.3 UCB Pharma (BE) Transdermal Preparation Product and Services
8.31.4 UCB Pharma (BE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.31.5 UCB Pharma (BE) Recent Developments/Updates
8.31.6 UCB Pharma (BE) Competitive Strengths & Weaknesses
8.32 Upsher-Smith Laboratories (US)
8.32.1 Upsher-Smith Laboratories (US) Details
8.32.2 Upsher-Smith Laboratories (US) Major Business
8.32.3 Upsher-Smith Laboratories (US) Transdermal Preparation Product and Services
8.32.4 Upsher-Smith Laboratories (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.32.5 Upsher-Smith Laboratories (US) Recent Developments/Updates
8.32.6 Upsher-Smith Laboratories (US) Competitive Strengths & Weaknesses
8.33 Henan Lingrui Pharmaceutical Co., Ltd. (CN)
8.33.1 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Details
8.33.2 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Major Business
8.33.3 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
8.33.4 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.33.5 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
8.33.6 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
8.34 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN)
8.34.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Details
8.34.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Major Business
8.34.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
8.34.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.34.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
8.34.6 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Transdermal Preparation Industry Chain
9.2 Transdermal Preparation Upstream Analysis
9.2.1 Transdermal Preparation Core Raw Materials
9.2.2 Main Manufacturers of Transdermal Preparation Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Transdermal Preparation Production Mode
9.6 Transdermal Preparation Procurement Model
9.7 Transdermal Preparation Industry Sales Model and Sales Channels
9.7.1 Transdermal Preparation Sales Model
9.7.2 Transdermal Preparation Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Transdermal Preparation Introduction
1.2 World Transdermal Preparation Supply & Forecast
1.2.1 World Transdermal Preparation Production Value (2021 & 2025 & 2032)
1.2.2 World Transdermal Preparation Production (2021-2032)
1.2.3 World Transdermal Preparation Pricing Trends (2021-2032)
1.3 World Transdermal Preparation Production by Region (Based on Production Site)
1.3.1 World Transdermal Preparation Production Value by Region (2021-2032)
1.3.2 World Transdermal Preparation Production by Region (2021-2032)
1.3.3 World Transdermal Preparation Average Price by Region (2021-2032)
1.3.4 North America Transdermal Preparation Production (2021-2032)
1.3.5 Europe Transdermal Preparation Production (2021-2032)
1.3.6 China Transdermal Preparation Production (2021-2032)
1.3.7 Japan Transdermal Preparation Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transdermal Preparation Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transdermal Preparation Major Market Trends
2 DEMAND SUMMARY
2.1 World Transdermal Preparation Demand (2021-2032)
2.2 World Transdermal Preparation Consumption by Region
2.2.1 World Transdermal Preparation Consumption by Region (2021-2026)
2.2.2 World Transdermal Preparation Consumption Forecast by Region (2027-2032)
2.3 United States Transdermal Preparation Consumption (2021-2032)
2.4 China Transdermal Preparation Consumption (2021-2032)
2.5 Europe Transdermal Preparation Consumption (2021-2032)
2.6 Japan Transdermal Preparation Consumption (2021-2032)
2.7 South Korea Transdermal Preparation Consumption (2021-2032)
2.8 ASEAN Transdermal Preparation Consumption (2021-2032)
2.9 India Transdermal Preparation Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transdermal Preparation Production Value by Manufacturer (2021-2026)
3.2 World Transdermal Preparation Production by Manufacturer (2021-2026)
3.3 World Transdermal Preparation Average Price by Manufacturer (2021-2026)
3.4 Transdermal Preparation Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transdermal Preparation Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transdermal Preparation in 2025
3.5.3 Global Concentration Ratios (CR8) for Transdermal Preparation in 2025
3.6 Transdermal Preparation Market: Overall Company Footprint Analysis
3.6.1 Transdermal Preparation Market: Region Footprint
3.6.2 Transdermal Preparation Market: Company Product Type Footprint
3.6.3 Transdermal Preparation Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transdermal Preparation Production Value Comparison
4.1.1 United States VS China: Transdermal Preparation Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Transdermal Preparation Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Transdermal Preparation Production Comparison
4.2.1 United States VS China: Transdermal Preparation Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transdermal Preparation Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Transdermal Preparation Consumption Comparison
4.3.1 United States VS China: Transdermal Preparation Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Transdermal Preparation Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Transdermal Preparation Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Transdermal Preparation Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.4.3 United States Based Manufacturers Transdermal Preparation Production (2021-2026)
4.5 China Based Transdermal Preparation Manufacturers and Market Share
4.5.1 China Based Transdermal Preparation Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.5.3 China Based Manufacturers Transdermal Preparation Production (2021-2026)
4.6 Rest of World Based Transdermal Preparation Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Transdermal Preparation Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transdermal Preparation Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Transdermal Preparation Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transdermal Preparation Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Injectable Preparations
5.2.2 Non Injectable Preparations
5.3 Market Segment by Type
5.3.1 World Transdermal Preparation Production by Type (2021-2032)
5.3.2 World Transdermal Preparation Production Value by Type (2021-2032)
5.3.3 World Transdermal Preparation Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Transdermal Preparation Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Patch
6.2.2 Cataplasm Hydrogel Patch
6.2.3 Hot Melt Adhesive Patch
6.2.4 Other
6.3 Market Segment by Dosage Form
6.3.1 World Transdermal Preparation Production by Dosage Form (2021-2032)
6.3.2 World Transdermal Preparation Production Value by Dosage Form (2021-2032)
6.3.3 World Transdermal Preparation Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Transdermal Preparation Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Other
7.3 Market Segment by Application
7.3.1 World Transdermal Preparation Production by Application (2021-2032)
7.3.2 World Transdermal Preparation Production Value by Application (2021-2032)
7.3.3 World Transdermal Preparation Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 3M (US)
8.1.1 3M (US) Details
8.1.2 3M (US) Major Business
8.1.3 3M (US) Transdermal Preparation Product and Services
8.1.4 3M (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 3M (US) Recent Developments/Updates
8.1.6 3M (US) Competitive Strengths & Weaknesses
8.2 AdhexPharma (FR)
8.2.1 AdhexPharma (FR) Details
8.2.2 AdhexPharma (FR) Major Business
8.2.3 AdhexPharma (FR) Transdermal Preparation Product and Services
8.2.4 AdhexPharma (FR) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 AdhexPharma (FR) Recent Developments/Updates
8.2.6 AdhexPharma (FR) Competitive Strengths & Weaknesses
8.3 Bayer AG (DE)
8.3.1 Bayer AG (DE) Details
8.3.2 Bayer AG (DE) Major Business
8.3.3 Bayer AG (DE) Transdermal Preparation Product and Services
8.3.4 Bayer AG (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Bayer AG (DE) Recent Developments/Updates
8.3.6 Bayer AG (DE) Competitive Strengths & Weaknesses
8.4 Boehringer Ingelheim (DE)
8.4.1 Boehringer Ingelheim (DE) Details
8.4.2 Boehringer Ingelheim (DE) Major Business
8.4.3 Boehringer Ingelheim (DE) Transdermal Preparation Product and Services
8.4.4 Boehringer Ingelheim (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Boehringer Ingelheim (DE) Recent Developments/Updates
8.4.6 Boehringer Ingelheim (DE) Competitive Strengths & Weaknesses
8.5 Corium (US)
8.5.1 Corium (US) Details
8.5.2 Corium (US) Major Business
8.5.3 Corium (US) Transdermal Preparation Product and Services
8.5.4 Corium (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Corium (US) Recent Developments/Updates
8.5.6 Corium (US) Competitive Strengths & Weaknesses
8.6 Endo International (IE)
8.6.1 Endo International (IE) Details
8.6.2 Endo International (IE) Major Business
8.6.3 Endo International (IE) Transdermal Preparation Product and Services
8.6.4 Endo International (IE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Endo International (IE) Recent Developments/Updates
8.6.6 Endo International (IE) Competitive Strengths & Weaknesses
8.7 GlaxoSmithKline (GSK) (GB)
8.7.1 GlaxoSmithKline (GSK) (GB) Details
8.7.2 GlaxoSmithKline (GSK) (GB) Major Business
8.7.3 GlaxoSmithKline (GSK) (GB) Transdermal Preparation Product and Services
8.7.4 GlaxoSmithKline (GSK) (GB) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 GlaxoSmithKline (GSK) (GB) Recent Developments/Updates
8.7.6 GlaxoSmithKline (GSK) (GB) Competitive Strengths & Weaknesses
8.8 Gr?nenthal Group (DE)
8.8.1 Gr?nenthal Group (DE) Details
8.8.2 Gr?nenthal Group (DE) Major Business
8.8.3 Gr?nenthal Group (DE) Transdermal Preparation Product and Services
8.8.4 Gr?nenthal Group (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Gr?nenthal Group (DE) Recent Developments/Updates
8.8.6 Gr?nenthal Group (DE) Competitive Strengths & Weaknesses
8.9 Henkel (DE)
8.9.1 Henkel (DE) Details
8.9.2 Henkel (DE) Major Business
8.9.3 Henkel (DE) Transdermal Preparation Product and Services
8.9.4 Henkel (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Henkel (DE) Recent Developments/Updates
8.9.6 Henkel (DE) Competitive Strengths & Weaknesses
8.10 Hisamitsu Pharmaceutical (JP)
8.10.1 Hisamitsu Pharmaceutical (JP) Details
8.10.2 Hisamitsu Pharmaceutical (JP) Major Business
8.10.3 Hisamitsu Pharmaceutical (JP) Transdermal Preparation Product and Services
8.10.4 Hisamitsu Pharmaceutical (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Hisamitsu Pharmaceutical (JP) Recent Developments/Updates
8.10.6 Hisamitsu Pharmaceutical (JP) Competitive Strengths & Weaknesses
8.11 IBSA Group (CH)
8.11.1 IBSA Group (CH) Details
8.11.2 IBSA Group (CH) Major Business
8.11.3 IBSA Group (CH) Transdermal Preparation Product and Services
8.11.4 IBSA Group (CH) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 IBSA Group (CH) Recent Developments/Updates
8.11.6 IBSA Group (CH) Competitive Strengths & Weaknesses
8.12 Johnson & Johnson (US)
8.12.1 Johnson & Johnson (US) Details
8.12.2 Johnson & Johnson (US) Major Business
8.12.3 Johnson & Johnson (US) Transdermal Preparation Product and Services
8.12.4 Johnson & Johnson (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Johnson & Johnson (US) Recent Developments/Updates
8.12.6 Johnson & Johnson (US) Competitive Strengths & Weaknesses
8.13 Luye Pharma Group (HK)
8.13.1 Luye Pharma Group (HK) Details
8.13.2 Luye Pharma Group (HK) Major Business
8.13.3 Luye Pharma Group (HK) Transdermal Preparation Product and Services
8.13.4 Luye Pharma Group (HK) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Luye Pharma Group (HK) Recent Developments/Updates
8.13.6 Luye Pharma Group (HK) Competitive Strengths & Weaknesses
8.14 LTS Lohmann Therapie-Systeme AG (DE)
8.14.1 LTS Lohmann Therapie-Systeme AG (DE) Details
8.14.2 LTS Lohmann Therapie-Systeme AG (DE) Major Business
8.14.3 LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Product and Services
8.14.4 LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 LTS Lohmann Therapie-Systeme AG (DE) Recent Developments/Updates
8.14.6 LTS Lohmann Therapie-Systeme AG (DE) Competitive Strengths & Weaknesses
8.15 Mitsubishi Tanabe Pharma Corporation (JP)
8.15.1 Mitsubishi Tanabe Pharma Corporation (JP) Details
8.15.2 Mitsubishi Tanabe Pharma Corporation (JP) Major Business
8.15.3 Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Product and Services
8.15.4 Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Mitsubishi Tanabe Pharma Corporation (JP) Recent Developments/Updates
8.15.6 Mitsubishi Tanabe Pharma Corporation (JP) Competitive Strengths & Weaknesses
8.16 Mundipharma (GB)
8.16.1 Mundipharma (GB) Details
8.16.2 Mundipharma (GB) Major Business
8.16.3 Mundipharma (GB) Transdermal Preparation Product and Services
8.16.4 Mundipharma (GB) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 Mundipharma (GB) Recent Developments/Updates
8.16.6 Mundipharma (GB) Competitive Strengths & Weaknesses
8.17 Mylan (Viatris) (US)
8.17.1 Mylan (Viatris) (US) Details
8.17.2 Mylan (Viatris) (US) Major Business
8.17.3 Mylan (Viatris) (US) Transdermal Preparation Product and Services
8.17.4 Mylan (Viatris) (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Mylan (Viatris) (US) Recent Developments/Updates
8.17.6 Mylan (Viatris) (US) Competitive Strengths & Weaknesses
8.18 Nitto Denko Corporation (JP)
8.18.1 Nitto Denko Corporation (JP) Details
8.18.2 Nitto Denko Corporation (JP) Major Business
8.18.3 Nitto Denko Corporation (JP) Transdermal Preparation Product and Services
8.18.4 Nitto Denko Corporation (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 Nitto Denko Corporation (JP) Recent Developments/Updates
8.18.6 Nitto Denko Corporation (JP) Competitive Strengths & Weaknesses
8.19 Noven Pharmaceuticals (US)
8.19.1 Noven Pharmaceuticals (US) Details
8.19.2 Noven Pharmaceuticals (US) Major Business
8.19.3 Noven Pharmaceuticals (US) Transdermal Preparation Product and Services
8.19.4 Noven Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.19.5 Noven Pharmaceuticals (US) Recent Developments/Updates
8.19.6 Noven Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.20 Novartis AG (CH)
8.20.1 Novartis AG (CH) Details
8.20.2 Novartis AG (CH) Major Business
8.20.3 Novartis AG (CH) Transdermal Preparation Product and Services
8.20.4 Novartis AG (CH) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.20.5 Novartis AG (CH) Recent Developments/Updates
8.20.6 Novartis AG (CH) Competitive Strengths & Weaknesses
8.21 Perrigo Company plc (IE)
8.21.1 Perrigo Company plc (IE) Details
8.21.2 Perrigo Company plc (IE) Major Business
8.21.3 Perrigo Company plc (IE) Transdermal Preparation Product and Services
8.21.4 Perrigo Company plc (IE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.21.5 Perrigo Company plc (IE) Recent Developments/Updates
8.21.6 Perrigo Company plc (IE) Competitive Strengths & Weaknesses
8.22 ProSolus, Inc. (US)
8.22.1 ProSolus, Inc. (US) Details
8.22.2 ProSolus, Inc. (US) Major Business
8.22.3 ProSolus, Inc. (US) Transdermal Preparation Product and Services
8.22.4 ProSolus, Inc. (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.22.5 ProSolus, Inc. (US) Recent Developments/Updates
8.22.6 ProSolus, Inc. (US) Competitive Strengths & Weaknesses
8.23 Purdue Pharma L.P. (US)
8.23.1 Purdue Pharma L.P. (US) Details
8.23.2 Purdue Pharma L.P. (US) Major Business
8.23.3 Purdue Pharma L.P. (US) Transdermal Preparation Product and Services
8.23.4 Purdue Pharma L.P. (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.23.5 Purdue Pharma L.P. (US) Recent Developments/Updates
8.23.6 Purdue Pharma L.P. (US) Competitive Strengths & Weaknesses
8.24 Scilex Pharmaceuticals (US)
8.24.1 Scilex Pharmaceuticals (US) Details
8.24.2 Scilex Pharmaceuticals (US) Major Business
8.24.3 Scilex Pharmaceuticals (US) Transdermal Preparation Product and Services
8.24.4 Scilex Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.24.5 Scilex Pharmaceuticals (US) Recent Developments/Updates
8.24.6 Scilex Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.25 Sino-American Tianjin Squibb (CN)
8.25.1 Sino-American Tianjin Squibb (CN) Details
8.25.2 Sino-American Tianjin Squibb (CN) Major Business
8.25.3 Sino-American Tianjin Squibb (CN) Transdermal Preparation Product and Services
8.25.4 Sino-American Tianjin Squibb (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.25.5 Sino-American Tianjin Squibb (CN) Recent Developments/Updates
8.25.6 Sino-American Tianjin Squibb (CN) Competitive Strengths & Weaknesses
8.26 SOLA Pharmaceuticals (US)
8.26.1 SOLA Pharmaceuticals (US) Details
8.26.2 SOLA Pharmaceuticals (US) Major Business
8.26.3 SOLA Pharmaceuticals (US) Transdermal Preparation Product and Services
8.26.4 SOLA Pharmaceuticals (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.26.5 SOLA Pharmaceuticals (US) Recent Developments/Updates
8.26.6 SOLA Pharmaceuticals (US) Competitive Strengths & Weaknesses
8.27 Sun Pharmaceutical Industries Ltd. (IN)
8.27.1 Sun Pharmaceutical Industries Ltd. (IN) Details
8.27.2 Sun Pharmaceutical Industries Ltd. (IN) Major Business
8.27.3 Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Product and Services
8.27.4 Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.27.5 Sun Pharmaceutical Industries Ltd. (IN) Recent Developments/Updates
8.27.6 Sun Pharmaceutical Industries Ltd. (IN) Competitive Strengths & Weaknesses
8.28 Tapemark (US)
8.28.1 Tapemark (US) Details
8.28.2 Tapemark (US) Major Business
8.28.3 Tapemark (US) Transdermal Preparation Product and Services
8.28.4 Tapemark (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.28.5 Tapemark (US) Recent Developments/Updates
8.28.6 Tapemark (US) Competitive Strengths & Weaknesses
8.29 Teikoku Seiyaku Co., Ltd. (JP)
8.29.1 Teikoku Seiyaku Co., Ltd. (JP) Details
8.29.2 Teikoku Seiyaku Co., Ltd. (JP) Major Business
8.29.3 Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Product and Services
8.29.4 Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.29.5 Teikoku Seiyaku Co., Ltd. (JP) Recent Developments/Updates
8.29.6 Teikoku Seiyaku Co., Ltd. (JP) Competitive Strengths & Weaknesses
8.30 Teva Pharmaceutical Industries Ltd. (IL)
8.30.1 Teva Pharmaceutical Industries Ltd. (IL) Details
8.30.2 Teva Pharmaceutical Industries Ltd. (IL) Major Business
8.30.3 Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Product and Services
8.30.4 Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.30.5 Teva Pharmaceutical Industries Ltd. (IL) Recent Developments/Updates
8.30.6 Teva Pharmaceutical Industries Ltd. (IL) Competitive Strengths & Weaknesses
8.31 UCB Pharma (BE)
8.31.1 UCB Pharma (BE) Details
8.31.2 UCB Pharma (BE) Major Business
8.31.3 UCB Pharma (BE) Transdermal Preparation Product and Services
8.31.4 UCB Pharma (BE) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.31.5 UCB Pharma (BE) Recent Developments/Updates
8.31.6 UCB Pharma (BE) Competitive Strengths & Weaknesses
8.32 Upsher-Smith Laboratories (US)
8.32.1 Upsher-Smith Laboratories (US) Details
8.32.2 Upsher-Smith Laboratories (US) Major Business
8.32.3 Upsher-Smith Laboratories (US) Transdermal Preparation Product and Services
8.32.4 Upsher-Smith Laboratories (US) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.32.5 Upsher-Smith Laboratories (US) Recent Developments/Updates
8.32.6 Upsher-Smith Laboratories (US) Competitive Strengths & Weaknesses
8.33 Henan Lingrui Pharmaceutical Co., Ltd. (CN)
8.33.1 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Details
8.33.2 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Major Business
8.33.3 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
8.33.4 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.33.5 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
8.33.6 Henan Lingrui Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
8.34 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN)
8.34.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Details
8.34.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Major Business
8.34.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
8.34.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.34.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
8.34.6 Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Transdermal Preparation Industry Chain
9.2 Transdermal Preparation Upstream Analysis
9.2.1 Transdermal Preparation Core Raw Materials
9.2.2 Main Manufacturers of Transdermal Preparation Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Transdermal Preparation Production Mode
9.6 Transdermal Preparation Procurement Model
9.7 Transdermal Preparation Industry Sales Model and Sales Channels
9.7.1 Transdermal Preparation Sales Model
9.7.2 Transdermal Preparation Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Transdermal Preparation Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Transdermal Preparation Production Value by Region (2021-2026) & (USD Million)
Table 3. World Transdermal Preparation Production Value by Region (2027-2032) & (USD Million)
Table 4. World Transdermal Preparation Production Value Market Share by Region (2021-2026)
Table 5. World Transdermal Preparation Production Value Market Share by Region (2027-2032)
Table 6. World Transdermal Preparation Production by Region (2021-2026) & (K Units)
Table 7. World Transdermal Preparation Production by Region (2027-2032) & (K Units)
Table 8. World Transdermal Preparation Production Market Share by Region (2021-2026)
Table 9. World Transdermal Preparation Production Market Share by Region (2027-2032)
Table 10. World Transdermal Preparation Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Transdermal Preparation Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Transdermal Preparation Major Market Trends
Table 13. World Transdermal Preparation Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Transdermal Preparation Consumption by Region (2021-2026) & (K Units)
Table 15. World Transdermal Preparation Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Transdermal Preparation Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Transdermal Preparation Producers in 2025
Table 18. World Transdermal Preparation Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Transdermal Preparation Producers in 2025
Table 20. World Transdermal Preparation Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Transdermal Preparation Company Evaluation Quadrant
Table 22. World Transdermal Preparation Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Transdermal Preparation Production Site of Key Manufacturer
Table 24. Transdermal Preparation Market: Company Product Type Footprint
Table 25. Transdermal Preparation Market: Company Product Application Footprint
Table 26. Transdermal Preparation Competitive Factors
Table 27. Transdermal Preparation New Entrant and Capacity Expansion Plans
Table 28. Transdermal Preparation Mergers & Acquisitions Activity
Table 29. United States VS China Transdermal Preparation Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Transdermal Preparation Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Transdermal Preparation Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Transdermal Preparation Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Transdermal Preparation Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 37. China Based Transdermal Preparation Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Transdermal Preparation Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 42. Rest of World Based Transdermal Preparation Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Transdermal Preparation Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 47. World Transdermal Preparation Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Transdermal Preparation Production by Type (2021-2026) & (K Units)
Table 49. World Transdermal Preparation Production by Type (2027-2032) & (K Units)
Table 50. World Transdermal Preparation Production Value by Type (2021-2026) & (USD Million)
Table 51. World Transdermal Preparation Production Value by Type (2027-2032) & (USD Million)
Table 52. World Transdermal Preparation Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Transdermal Preparation Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Transdermal Preparation Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Transdermal Preparation Production by Dosage Form (2021-2026) & (K Units)
Table 56. World Transdermal Preparation Production by Dosage Form (2027-2032) & (K Units)
Table 57. World Transdermal Preparation Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Transdermal Preparation Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Transdermal Preparation Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Transdermal Preparation Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Transdermal Preparation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Transdermal Preparation Production by Application (2021-2026) & (K Units)
Table 63. World Transdermal Preparation Production by Application (2027-2032) & (K Units)
Table 64. World Transdermal Preparation Production Value by Application (2021-2026) & (USD Million)
Table 65. World Transdermal Preparation Production Value by Application (2027-2032) & (USD Million)
Table 66. World Transdermal Preparation Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Transdermal Preparation Average Price by Application (2027-2032) & (US$/Unit)
Table 68. 3M (US) Basic Information, Manufacturing Base and Competitors
Table 69. 3M (US) Major Business
Table 70. 3M (US) Transdermal Preparation Product and Services
Table 71. 3M (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. 3M (US) Recent Developments/Updates
Table 73. 3M (US) Competitive Strengths & Weaknesses
Table 74. AdhexPharma (FR) Basic Information, Manufacturing Base and Competitors
Table 75. AdhexPharma (FR) Major Business
Table 76. AdhexPharma (FR) Transdermal Preparation Product and Services
Table 77. AdhexPharma (FR) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. AdhexPharma (FR) Recent Developments/Updates
Table 79. AdhexPharma (FR) Competitive Strengths & Weaknesses
Table 80. Bayer AG (DE) Basic Information, Manufacturing Base and Competitors
Table 81. Bayer AG (DE) Major Business
Table 82. Bayer AG (DE) Transdermal Preparation Product and Services
Table 83. Bayer AG (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Bayer AG (DE) Recent Developments/Updates
Table 85. Bayer AG (DE) Competitive Strengths & Weaknesses
Table 86. Boehringer Ingelheim (DE) Basic Information, Manufacturing Base and Competitors
Table 87. Boehringer Ingelheim (DE) Major Business
Table 88. Boehringer Ingelheim (DE) Transdermal Preparation Product and Services
Table 89. Boehringer Ingelheim (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Boehringer Ingelheim (DE) Recent Developments/Updates
Table 91. Boehringer Ingelheim (DE) Competitive Strengths & Weaknesses
Table 92. Corium (US) Basic Information, Manufacturing Base and Competitors
Table 93. Corium (US) Major Business
Table 94. Corium (US) Transdermal Preparation Product and Services
Table 95. Corium (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Corium (US) Recent Developments/Updates
Table 97. Corium (US) Competitive Strengths & Weaknesses
Table 98. Endo International (IE) Basic Information, Manufacturing Base and Competitors
Table 99. Endo International (IE) Major Business
Table 100. Endo International (IE) Transdermal Preparation Product and Services
Table 101. Endo International (IE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Endo International (IE) Recent Developments/Updates
Table 103. Endo International (IE) Competitive Strengths & Weaknesses
Table 104. GlaxoSmithKline (GSK) (GB) Basic Information, Manufacturing Base and Competitors
Table 105. GlaxoSmithKline (GSK) (GB) Major Business
Table 106. GlaxoSmithKline (GSK) (GB) Transdermal Preparation Product and Services
Table 107. GlaxoSmithKline (GSK) (GB) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. GlaxoSmithKline (GSK) (GB) Recent Developments/Updates
Table 109. GlaxoSmithKline (GSK) (GB) Competitive Strengths & Weaknesses
Table 110. Gr?nenthal Group (DE) Basic Information, Manufacturing Base and Competitors
Table 111. Gr?nenthal Group (DE) Major Business
Table 112. Gr?nenthal Group (DE) Transdermal Preparation Product and Services
Table 113. Gr?nenthal Group (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Gr?nenthal Group (DE) Recent Developments/Updates
Table 115. Gr?nenthal Group (DE) Competitive Strengths & Weaknesses
Table 116. Henkel (DE) Basic Information, Manufacturing Base and Competitors
Table 117. Henkel (DE) Major Business
Table 118. Henkel (DE) Transdermal Preparation Product and Services
Table 119. Henkel (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Henkel (DE) Recent Developments/Updates
Table 121. Henkel (DE) Competitive Strengths & Weaknesses
Table 122. Hisamitsu Pharmaceutical (JP) Basic Information, Manufacturing Base and Competitors
Table 123. Hisamitsu Pharmaceutical (JP) Major Business
Table 124. Hisamitsu Pharmaceutical (JP) Transdermal Preparation Product and Services
Table 125. Hisamitsu Pharmaceutical (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Hisamitsu Pharmaceutical (JP) Recent Developments/Updates
Table 127. Hisamitsu Pharmaceutical (JP) Competitive Strengths & Weaknesses
Table 128. IBSA Group (CH) Basic Information, Manufacturing Base and Competitors
Table 129. IBSA Group (CH) Major Business
Table 130. IBSA Group (CH) Transdermal Preparation Product and Services
Table 131. IBSA Group (CH) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. IBSA Group (CH) Recent Developments/Updates
Table 133. IBSA Group (CH) Competitive Strengths & Weaknesses
Table 134. Johnson & Johnson (US) Basic Information, Manufacturing Base and Competitors
Table 135. Johnson & Johnson (US) Major Business
Table 136. Johnson & Johnson (US) Transdermal Preparation Product and Services
Table 137. Johnson & Johnson (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Johnson & Johnson (US) Recent Developments/Updates
Table 139. Johnson & Johnson (US) Competitive Strengths & Weaknesses
Table 140. Luye Pharma Group (HK) Basic Information, Manufacturing Base and Competitors
Table 141. Luye Pharma Group (HK) Major Business
Table 142. Luye Pharma Group (HK) Transdermal Preparation Product and Services
Table 143. Luye Pharma Group (HK) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Luye Pharma Group (HK) Recent Developments/Updates
Table 145. Luye Pharma Group (HK) Competitive Strengths & Weaknesses
Table 146. LTS Lohmann Therapie-Systeme AG (DE) Basic Information, Manufacturing Base and Competitors
Table 147. LTS Lohmann Therapie-Systeme AG (DE) Major Business
Table 148. LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Product and Services
Table 149. LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. LTS Lohmann Therapie-Systeme AG (DE) Recent Developments/Updates
Table 151. LTS Lohmann Therapie-Systeme AG (DE) Competitive Strengths & Weaknesses
Table 152. Mitsubishi Tanabe Pharma Corporation (JP) Basic Information, Manufacturing Base and Competitors
Table 153. Mitsubishi Tanabe Pharma Corporation (JP) Major Business
Table 154. Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Product and Services
Table 155. Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Mitsubishi Tanabe Pharma Corporation (JP) Recent Developments/Updates
Table 157. Mitsubishi Tanabe Pharma Corporation (JP) Competitive Strengths & Weaknesses
Table 158. Mundipharma (GB) Basic Information, Manufacturing Base and Competitors
Table 159. Mundipharma (GB) Major Business
Table 160. Mundipharma (GB) Transdermal Preparation Product and Services
Table 161. Mundipharma (GB) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Mundipharma (GB) Recent Developments/Updates
Table 163. Mundipharma (GB) Competitive Strengths & Weaknesses
Table 164. Mylan (Viatris) (US) Basic Information, Manufacturing Base and Competitors
Table 165. Mylan (Viatris) (US) Major Business
Table 166. Mylan (Viatris) (US) Transdermal Preparation Product and Services
Table 167. Mylan (Viatris) (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Mylan (Viatris) (US) Recent Developments/Updates
Table 169. Mylan (Viatris) (US) Competitive Strengths & Weaknesses
Table 170. Nitto Denko Corporation (JP) Basic Information, Manufacturing Base and Competitors
Table 171. Nitto Denko Corporation (JP) Major Business
Table 172. Nitto Denko Corporation (JP) Transdermal Preparation Product and Services
Table 173. Nitto Denko Corporation (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. Nitto Denko Corporation (JP) Recent Developments/Updates
Table 175. Nitto Denko Corporation (JP) Competitive Strengths & Weaknesses
Table 176. Noven Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 177. Noven Pharmaceuticals (US) Major Business
Table 178. Noven Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 179. Noven Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Noven Pharmaceuticals (US) Recent Developments/Updates
Table 181. Noven Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 182. Novartis AG (CH) Basic Information, Manufacturing Base and Competitors
Table 183. Novartis AG (CH) Major Business
Table 184. Novartis AG (CH) Transdermal Preparation Product and Services
Table 185. Novartis AG (CH) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 186. Novartis AG (CH) Recent Developments/Updates
Table 187. Novartis AG (CH) Competitive Strengths & Weaknesses
Table 188. Perrigo Company plc (IE) Basic Information, Manufacturing Base and Competitors
Table 189. Perrigo Company plc (IE) Major Business
Table 190. Perrigo Company plc (IE) Transdermal Preparation Product and Services
Table 191. Perrigo Company plc (IE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 192. Perrigo Company plc (IE) Recent Developments/Updates
Table 193. Perrigo Company plc (IE) Competitive Strengths & Weaknesses
Table 194. ProSolus, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 195. ProSolus, Inc. (US) Major Business
Table 196. ProSolus, Inc. (US) Transdermal Preparation Product and Services
Table 197. ProSolus, Inc. (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 198. ProSolus, Inc. (US) Recent Developments/Updates
Table 199. ProSolus, Inc. (US) Competitive Strengths & Weaknesses
Table 200. Purdue Pharma L.P. (US) Basic Information, Manufacturing Base and Competitors
Table 201. Purdue Pharma L.P. (US) Major Business
Table 202. Purdue Pharma L.P. (US) Transdermal Preparation Product and Services
Table 203. Purdue Pharma L.P. (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 204. Purdue Pharma L.P. (US) Recent Developments/Updates
Table 205. Purdue Pharma L.P. (US) Competitive Strengths & Weaknesses
Table 206. Scilex Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 207. Scilex Pharmaceuticals (US) Major Business
Table 208. Scilex Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 209. Scilex Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 210. Scilex Pharmaceuticals (US) Recent Developments/Updates
Table 211. Scilex Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 212. Sino-American Tianjin Squibb (CN) Basic Information, Manufacturing Base and Competitors
Table 213. Sino-American Tianjin Squibb (CN) Major Business
Table 214. Sino-American Tianjin Squibb (CN) Transdermal Preparation Product and Services
Table 215. Sino-American Tianjin Squibb (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 216. Sino-American Tianjin Squibb (CN) Recent Developments/Updates
Table 217. Sino-American Tianjin Squibb (CN) Competitive Strengths & Weaknesses
Table 218. SOLA Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 219. SOLA Pharmaceuticals (US) Major Business
Table 220. SOLA Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 221. SOLA Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 222. SOLA Pharmaceuticals (US) Recent Developments/Updates
Table 223. SOLA Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 224. Sun Pharmaceutical Industries Ltd. (IN) Basic Information, Manufacturing Base and Competitors
Table 225. Sun Pharmaceutical Industries Ltd. (IN) Major Business
Table 226. Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Product and Services
Table 227. Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 228. Sun Pharmaceutical Industries Ltd. (IN) Recent Developments/Updates
Table 229. Sun Pharmaceutical Industries Ltd. (IN) Competitive Strengths & Weaknesses
Table 230. Tapemark (US) Basic Information, Manufacturing Base and Competitors
Table 231. Tapemark (US) Major Business
Table 232. Tapemark (US) Transdermal Preparation Product and Services
Table 233. Tapemark (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 234. Tapemark (US) Recent Developments/Updates
Table 235. Tapemark (US) Competitive Strengths & Weaknesses
Table 236. Teikoku Seiyaku Co., Ltd. (JP) Basic Information, Manufacturing Base and Competitors
Table 237. Teikoku Seiyaku Co., Ltd. (JP) Major Business
Table 238. Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Product and Services
Table 239. Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 240. Teikoku Seiyaku Co., Ltd. (JP) Recent Developments/Updates
Table 241. Teikoku Seiyaku Co., Ltd. (JP) Competitive Strengths & Weaknesses
Table 242. Teva Pharmaceutical Industries Ltd. (IL) Basic Information, Manufacturing Base and Competitors
Table 243. Teva Pharmaceutical Industries Ltd. (IL) Major Business
Table 244. Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Product and Services
Table 245. Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 246. Teva Pharmaceutical Industries Ltd. (IL) Recent Developments/Updates
Table 247. Teva Pharmaceutical Industries Ltd. (IL) Competitive Strengths & Weaknesses
Table 248. UCB Pharma (BE) Basic Information, Manufacturing Base and Competitors
Table 249. UCB Pharma (BE) Major Business
Table 250. UCB Pharma (BE) Transdermal Preparation Product and Services
Table 251. UCB Pharma (BE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 252. UCB Pharma (BE) Recent Developments/Updates
Table 253. UCB Pharma (BE) Competitive Strengths & Weaknesses
Table 254. Upsher-Smith Laboratories (US) Basic Information, Manufacturing Base and Competitors
Table 255. Upsher-Smith Laboratories (US) Major Business
Table 256. Upsher-Smith Laboratories (US) Transdermal Preparation Product and Services
Table 257. Upsher-Smith Laboratories (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 258. Upsher-Smith Laboratories (US) Recent Developments/Updates
Table 259. Upsher-Smith Laboratories (US) Competitive Strengths & Weaknesses
Table 260. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 261. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Major Business
Table 262. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
Table 263. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 264. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
Table 265. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 266. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 267. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Major Business
Table 268. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
Table 269. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 270. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
Table 271. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 272. Global Key Players of Transdermal Preparation Upstream (Raw Materials)
Table 273. Global Transdermal Preparation Typical Customers
Table 274. Transdermal Preparation Typical Distributors
Table 1. World Transdermal Preparation Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Transdermal Preparation Production Value by Region (2021-2026) & (USD Million)
Table 3. World Transdermal Preparation Production Value by Region (2027-2032) & (USD Million)
Table 4. World Transdermal Preparation Production Value Market Share by Region (2021-2026)
Table 5. World Transdermal Preparation Production Value Market Share by Region (2027-2032)
Table 6. World Transdermal Preparation Production by Region (2021-2026) & (K Units)
Table 7. World Transdermal Preparation Production by Region (2027-2032) & (K Units)
Table 8. World Transdermal Preparation Production Market Share by Region (2021-2026)
Table 9. World Transdermal Preparation Production Market Share by Region (2027-2032)
Table 10. World Transdermal Preparation Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Transdermal Preparation Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Transdermal Preparation Major Market Trends
Table 13. World Transdermal Preparation Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Transdermal Preparation Consumption by Region (2021-2026) & (K Units)
Table 15. World Transdermal Preparation Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Transdermal Preparation Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Transdermal Preparation Producers in 2025
Table 18. World Transdermal Preparation Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Transdermal Preparation Producers in 2025
Table 20. World Transdermal Preparation Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Transdermal Preparation Company Evaluation Quadrant
Table 22. World Transdermal Preparation Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Transdermal Preparation Production Site of Key Manufacturer
Table 24. Transdermal Preparation Market: Company Product Type Footprint
Table 25. Transdermal Preparation Market: Company Product Application Footprint
Table 26. Transdermal Preparation Competitive Factors
Table 27. Transdermal Preparation New Entrant and Capacity Expansion Plans
Table 28. Transdermal Preparation Mergers & Acquisitions Activity
Table 29. United States VS China Transdermal Preparation Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Transdermal Preparation Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Transdermal Preparation Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Transdermal Preparation Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Transdermal Preparation Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 37. China Based Transdermal Preparation Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Transdermal Preparation Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 42. Rest of World Based Transdermal Preparation Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Transdermal Preparation Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Transdermal Preparation Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Transdermal Preparation Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Transdermal Preparation Production Market Share (2021-2026)
Table 47. World Transdermal Preparation Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Transdermal Preparation Production by Type (2021-2026) & (K Units)
Table 49. World Transdermal Preparation Production by Type (2027-2032) & (K Units)
Table 50. World Transdermal Preparation Production Value by Type (2021-2026) & (USD Million)
Table 51. World Transdermal Preparation Production Value by Type (2027-2032) & (USD Million)
Table 52. World Transdermal Preparation Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Transdermal Preparation Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Transdermal Preparation Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Transdermal Preparation Production by Dosage Form (2021-2026) & (K Units)
Table 56. World Transdermal Preparation Production by Dosage Form (2027-2032) & (K Units)
Table 57. World Transdermal Preparation Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Transdermal Preparation Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Transdermal Preparation Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Transdermal Preparation Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Transdermal Preparation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Transdermal Preparation Production by Application (2021-2026) & (K Units)
Table 63. World Transdermal Preparation Production by Application (2027-2032) & (K Units)
Table 64. World Transdermal Preparation Production Value by Application (2021-2026) & (USD Million)
Table 65. World Transdermal Preparation Production Value by Application (2027-2032) & (USD Million)
Table 66. World Transdermal Preparation Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Transdermal Preparation Average Price by Application (2027-2032) & (US$/Unit)
Table 68. 3M (US) Basic Information, Manufacturing Base and Competitors
Table 69. 3M (US) Major Business
Table 70. 3M (US) Transdermal Preparation Product and Services
Table 71. 3M (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. 3M (US) Recent Developments/Updates
Table 73. 3M (US) Competitive Strengths & Weaknesses
Table 74. AdhexPharma (FR) Basic Information, Manufacturing Base and Competitors
Table 75. AdhexPharma (FR) Major Business
Table 76. AdhexPharma (FR) Transdermal Preparation Product and Services
Table 77. AdhexPharma (FR) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. AdhexPharma (FR) Recent Developments/Updates
Table 79. AdhexPharma (FR) Competitive Strengths & Weaknesses
Table 80. Bayer AG (DE) Basic Information, Manufacturing Base and Competitors
Table 81. Bayer AG (DE) Major Business
Table 82. Bayer AG (DE) Transdermal Preparation Product and Services
Table 83. Bayer AG (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Bayer AG (DE) Recent Developments/Updates
Table 85. Bayer AG (DE) Competitive Strengths & Weaknesses
Table 86. Boehringer Ingelheim (DE) Basic Information, Manufacturing Base and Competitors
Table 87. Boehringer Ingelheim (DE) Major Business
Table 88. Boehringer Ingelheim (DE) Transdermal Preparation Product and Services
Table 89. Boehringer Ingelheim (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Boehringer Ingelheim (DE) Recent Developments/Updates
Table 91. Boehringer Ingelheim (DE) Competitive Strengths & Weaknesses
Table 92. Corium (US) Basic Information, Manufacturing Base and Competitors
Table 93. Corium (US) Major Business
Table 94. Corium (US) Transdermal Preparation Product and Services
Table 95. Corium (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Corium (US) Recent Developments/Updates
Table 97. Corium (US) Competitive Strengths & Weaknesses
Table 98. Endo International (IE) Basic Information, Manufacturing Base and Competitors
Table 99. Endo International (IE) Major Business
Table 100. Endo International (IE) Transdermal Preparation Product and Services
Table 101. Endo International (IE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Endo International (IE) Recent Developments/Updates
Table 103. Endo International (IE) Competitive Strengths & Weaknesses
Table 104. GlaxoSmithKline (GSK) (GB) Basic Information, Manufacturing Base and Competitors
Table 105. GlaxoSmithKline (GSK) (GB) Major Business
Table 106. GlaxoSmithKline (GSK) (GB) Transdermal Preparation Product and Services
Table 107. GlaxoSmithKline (GSK) (GB) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. GlaxoSmithKline (GSK) (GB) Recent Developments/Updates
Table 109. GlaxoSmithKline (GSK) (GB) Competitive Strengths & Weaknesses
Table 110. Gr?nenthal Group (DE) Basic Information, Manufacturing Base and Competitors
Table 111. Gr?nenthal Group (DE) Major Business
Table 112. Gr?nenthal Group (DE) Transdermal Preparation Product and Services
Table 113. Gr?nenthal Group (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Gr?nenthal Group (DE) Recent Developments/Updates
Table 115. Gr?nenthal Group (DE) Competitive Strengths & Weaknesses
Table 116. Henkel (DE) Basic Information, Manufacturing Base and Competitors
Table 117. Henkel (DE) Major Business
Table 118. Henkel (DE) Transdermal Preparation Product and Services
Table 119. Henkel (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Henkel (DE) Recent Developments/Updates
Table 121. Henkel (DE) Competitive Strengths & Weaknesses
Table 122. Hisamitsu Pharmaceutical (JP) Basic Information, Manufacturing Base and Competitors
Table 123. Hisamitsu Pharmaceutical (JP) Major Business
Table 124. Hisamitsu Pharmaceutical (JP) Transdermal Preparation Product and Services
Table 125. Hisamitsu Pharmaceutical (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Hisamitsu Pharmaceutical (JP) Recent Developments/Updates
Table 127. Hisamitsu Pharmaceutical (JP) Competitive Strengths & Weaknesses
Table 128. IBSA Group (CH) Basic Information, Manufacturing Base and Competitors
Table 129. IBSA Group (CH) Major Business
Table 130. IBSA Group (CH) Transdermal Preparation Product and Services
Table 131. IBSA Group (CH) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. IBSA Group (CH) Recent Developments/Updates
Table 133. IBSA Group (CH) Competitive Strengths & Weaknesses
Table 134. Johnson & Johnson (US) Basic Information, Manufacturing Base and Competitors
Table 135. Johnson & Johnson (US) Major Business
Table 136. Johnson & Johnson (US) Transdermal Preparation Product and Services
Table 137. Johnson & Johnson (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Johnson & Johnson (US) Recent Developments/Updates
Table 139. Johnson & Johnson (US) Competitive Strengths & Weaknesses
Table 140. Luye Pharma Group (HK) Basic Information, Manufacturing Base and Competitors
Table 141. Luye Pharma Group (HK) Major Business
Table 142. Luye Pharma Group (HK) Transdermal Preparation Product and Services
Table 143. Luye Pharma Group (HK) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Luye Pharma Group (HK) Recent Developments/Updates
Table 145. Luye Pharma Group (HK) Competitive Strengths & Weaknesses
Table 146. LTS Lohmann Therapie-Systeme AG (DE) Basic Information, Manufacturing Base and Competitors
Table 147. LTS Lohmann Therapie-Systeme AG (DE) Major Business
Table 148. LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Product and Services
Table 149. LTS Lohmann Therapie-Systeme AG (DE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. LTS Lohmann Therapie-Systeme AG (DE) Recent Developments/Updates
Table 151. LTS Lohmann Therapie-Systeme AG (DE) Competitive Strengths & Weaknesses
Table 152. Mitsubishi Tanabe Pharma Corporation (JP) Basic Information, Manufacturing Base and Competitors
Table 153. Mitsubishi Tanabe Pharma Corporation (JP) Major Business
Table 154. Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Product and Services
Table 155. Mitsubishi Tanabe Pharma Corporation (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Mitsubishi Tanabe Pharma Corporation (JP) Recent Developments/Updates
Table 157. Mitsubishi Tanabe Pharma Corporation (JP) Competitive Strengths & Weaknesses
Table 158. Mundipharma (GB) Basic Information, Manufacturing Base and Competitors
Table 159. Mundipharma (GB) Major Business
Table 160. Mundipharma (GB) Transdermal Preparation Product and Services
Table 161. Mundipharma (GB) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. Mundipharma (GB) Recent Developments/Updates
Table 163. Mundipharma (GB) Competitive Strengths & Weaknesses
Table 164. Mylan (Viatris) (US) Basic Information, Manufacturing Base and Competitors
Table 165. Mylan (Viatris) (US) Major Business
Table 166. Mylan (Viatris) (US) Transdermal Preparation Product and Services
Table 167. Mylan (Viatris) (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Mylan (Viatris) (US) Recent Developments/Updates
Table 169. Mylan (Viatris) (US) Competitive Strengths & Weaknesses
Table 170. Nitto Denko Corporation (JP) Basic Information, Manufacturing Base and Competitors
Table 171. Nitto Denko Corporation (JP) Major Business
Table 172. Nitto Denko Corporation (JP) Transdermal Preparation Product and Services
Table 173. Nitto Denko Corporation (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. Nitto Denko Corporation (JP) Recent Developments/Updates
Table 175. Nitto Denko Corporation (JP) Competitive Strengths & Weaknesses
Table 176. Noven Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 177. Noven Pharmaceuticals (US) Major Business
Table 178. Noven Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 179. Noven Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Noven Pharmaceuticals (US) Recent Developments/Updates
Table 181. Noven Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 182. Novartis AG (CH) Basic Information, Manufacturing Base and Competitors
Table 183. Novartis AG (CH) Major Business
Table 184. Novartis AG (CH) Transdermal Preparation Product and Services
Table 185. Novartis AG (CH) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 186. Novartis AG (CH) Recent Developments/Updates
Table 187. Novartis AG (CH) Competitive Strengths & Weaknesses
Table 188. Perrigo Company plc (IE) Basic Information, Manufacturing Base and Competitors
Table 189. Perrigo Company plc (IE) Major Business
Table 190. Perrigo Company plc (IE) Transdermal Preparation Product and Services
Table 191. Perrigo Company plc (IE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 192. Perrigo Company plc (IE) Recent Developments/Updates
Table 193. Perrigo Company plc (IE) Competitive Strengths & Weaknesses
Table 194. ProSolus, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 195. ProSolus, Inc. (US) Major Business
Table 196. ProSolus, Inc. (US) Transdermal Preparation Product and Services
Table 197. ProSolus, Inc. (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 198. ProSolus, Inc. (US) Recent Developments/Updates
Table 199. ProSolus, Inc. (US) Competitive Strengths & Weaknesses
Table 200. Purdue Pharma L.P. (US) Basic Information, Manufacturing Base and Competitors
Table 201. Purdue Pharma L.P. (US) Major Business
Table 202. Purdue Pharma L.P. (US) Transdermal Preparation Product and Services
Table 203. Purdue Pharma L.P. (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 204. Purdue Pharma L.P. (US) Recent Developments/Updates
Table 205. Purdue Pharma L.P. (US) Competitive Strengths & Weaknesses
Table 206. Scilex Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 207. Scilex Pharmaceuticals (US) Major Business
Table 208. Scilex Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 209. Scilex Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 210. Scilex Pharmaceuticals (US) Recent Developments/Updates
Table 211. Scilex Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 212. Sino-American Tianjin Squibb (CN) Basic Information, Manufacturing Base and Competitors
Table 213. Sino-American Tianjin Squibb (CN) Major Business
Table 214. Sino-American Tianjin Squibb (CN) Transdermal Preparation Product and Services
Table 215. Sino-American Tianjin Squibb (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 216. Sino-American Tianjin Squibb (CN) Recent Developments/Updates
Table 217. Sino-American Tianjin Squibb (CN) Competitive Strengths & Weaknesses
Table 218. SOLA Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 219. SOLA Pharmaceuticals (US) Major Business
Table 220. SOLA Pharmaceuticals (US) Transdermal Preparation Product and Services
Table 221. SOLA Pharmaceuticals (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 222. SOLA Pharmaceuticals (US) Recent Developments/Updates
Table 223. SOLA Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 224. Sun Pharmaceutical Industries Ltd. (IN) Basic Information, Manufacturing Base and Competitors
Table 225. Sun Pharmaceutical Industries Ltd. (IN) Major Business
Table 226. Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Product and Services
Table 227. Sun Pharmaceutical Industries Ltd. (IN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 228. Sun Pharmaceutical Industries Ltd. (IN) Recent Developments/Updates
Table 229. Sun Pharmaceutical Industries Ltd. (IN) Competitive Strengths & Weaknesses
Table 230. Tapemark (US) Basic Information, Manufacturing Base and Competitors
Table 231. Tapemark (US) Major Business
Table 232. Tapemark (US) Transdermal Preparation Product and Services
Table 233. Tapemark (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 234. Tapemark (US) Recent Developments/Updates
Table 235. Tapemark (US) Competitive Strengths & Weaknesses
Table 236. Teikoku Seiyaku Co., Ltd. (JP) Basic Information, Manufacturing Base and Competitors
Table 237. Teikoku Seiyaku Co., Ltd. (JP) Major Business
Table 238. Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Product and Services
Table 239. Teikoku Seiyaku Co., Ltd. (JP) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 240. Teikoku Seiyaku Co., Ltd. (JP) Recent Developments/Updates
Table 241. Teikoku Seiyaku Co., Ltd. (JP) Competitive Strengths & Weaknesses
Table 242. Teva Pharmaceutical Industries Ltd. (IL) Basic Information, Manufacturing Base and Competitors
Table 243. Teva Pharmaceutical Industries Ltd. (IL) Major Business
Table 244. Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Product and Services
Table 245. Teva Pharmaceutical Industries Ltd. (IL) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 246. Teva Pharmaceutical Industries Ltd. (IL) Recent Developments/Updates
Table 247. Teva Pharmaceutical Industries Ltd. (IL) Competitive Strengths & Weaknesses
Table 248. UCB Pharma (BE) Basic Information, Manufacturing Base and Competitors
Table 249. UCB Pharma (BE) Major Business
Table 250. UCB Pharma (BE) Transdermal Preparation Product and Services
Table 251. UCB Pharma (BE) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 252. UCB Pharma (BE) Recent Developments/Updates
Table 253. UCB Pharma (BE) Competitive Strengths & Weaknesses
Table 254. Upsher-Smith Laboratories (US) Basic Information, Manufacturing Base and Competitors
Table 255. Upsher-Smith Laboratories (US) Major Business
Table 256. Upsher-Smith Laboratories (US) Transdermal Preparation Product and Services
Table 257. Upsher-Smith Laboratories (US) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 258. Upsher-Smith Laboratories (US) Recent Developments/Updates
Table 259. Upsher-Smith Laboratories (US) Competitive Strengths & Weaknesses
Table 260. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 261. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Major Business
Table 262. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
Table 263. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 264. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
Table 265. Henan Lingrui Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 266. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Basic Information, Manufacturing Base and Competitors
Table 267. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Major Business
Table 268. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Product and Services
Table 269. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Transdermal Preparation Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 270. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Recent Developments/Updates
Table 271. Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) Competitive Strengths & Weaknesses
Table 272. Global Key Players of Transdermal Preparation Upstream (Raw Materials)
Table 273. Global Transdermal Preparation Typical Customers
Table 274. Transdermal Preparation Typical Distributors
LIST OF FIGURES
Figure 1. Transdermal Preparation Picture
Figure 2. World Transdermal Preparation Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transdermal Preparation Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Transdermal Preparation Production (2021-2032) & (K Units)
Figure 5. World Transdermal Preparation Average Price (2021-2032) & (US$/Unit)
Figure 6. World Transdermal Preparation Production Value Market Share by Region (2021-2032)
Figure 7. World Transdermal Preparation Production Market Share by Region (2021-2032)
Figure 8. North America Transdermal Preparation Production (2021-2032) & (K Units)
Figure 9. Europe Transdermal Preparation Production (2021-2032) & (K Units)
Figure 10. China Transdermal Preparation Production (2021-2032) & (K Units)
Figure 11. Japan Transdermal Preparation Production (2021-2032) & (K Units)
Figure 12. Transdermal Preparation Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 15. World Transdermal Preparation Consumption Market Share by Region (2021-2032)
Figure 16. United States Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 17. China Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 18. Europe Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 19. Japan Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 20. South Korea Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 22. India Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Transdermal Preparation by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transdermal Preparation Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transdermal Preparation Markets in 2025
Figure 26. United States VS China: Transdermal Preparation Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Transdermal Preparation Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transdermal Preparation Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 30. China Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 32. World Transdermal Preparation Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Transdermal Preparation Production Value Market Share by Type in 2025
Figure 34. Injectable Preparations
Figure 35. Non Injectable Preparations
Figure 36. World Transdermal Preparation Production Market Share by Type (2021-2032)
Figure 37. World Transdermal Preparation Production Value Market Share by Type (2021-2032)
Figure 38. World Transdermal Preparation Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Transdermal Preparation Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 40. World Transdermal Preparation Production Value Market Share by Dosage Form in 2025
Figure 41. Patch
Figure 42. Cataplasm Hydrogel Patch
Figure 43. Hot Melt Adhesive Patch
Figure 44. Other
Figure 45. World Transdermal Preparation Production Market Share by Dosage Form (2021-2032)
Figure 46. World Transdermal Preparation Production Value Market Share by Dosage Form (2021-2032)
Figure 47. World Transdermal Preparation Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 48. ? 12.5 ?g/h
Figure 49. 12.5 ? 25 ?g/h
Figure 50. 25 ? 50 ?g/h
Figure 51. 50 ? 100 ?g/h
Figure 52. ? 100 ?g/h
Figure 53. World Transdermal Preparation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Transdermal Preparation Production Value Market Share by Application in 2025
Figure 55. Hospital
Figure 56. Clinic
Figure 57. Other
Figure 58. World Transdermal Preparation Production Market Share by Application (2021-2032)
Figure 59. World Transdermal Preparation Production Value Market Share by Application (2021-2032)
Figure 60. World Transdermal Preparation Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. Transdermal Preparation Industry Chain
Figure 62. Transdermal Preparation Procurement Model
Figure 63. Transdermal Preparation Sales Model
Figure 64. Transdermal Preparation Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. Transdermal Preparation Picture
Figure 2. World Transdermal Preparation Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transdermal Preparation Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Transdermal Preparation Production (2021-2032) & (K Units)
Figure 5. World Transdermal Preparation Average Price (2021-2032) & (US$/Unit)
Figure 6. World Transdermal Preparation Production Value Market Share by Region (2021-2032)
Figure 7. World Transdermal Preparation Production Market Share by Region (2021-2032)
Figure 8. North America Transdermal Preparation Production (2021-2032) & (K Units)
Figure 9. Europe Transdermal Preparation Production (2021-2032) & (K Units)
Figure 10. China Transdermal Preparation Production (2021-2032) & (K Units)
Figure 11. Japan Transdermal Preparation Production (2021-2032) & (K Units)
Figure 12. Transdermal Preparation Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 15. World Transdermal Preparation Consumption Market Share by Region (2021-2032)
Figure 16. United States Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 17. China Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 18. Europe Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 19. Japan Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 20. South Korea Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 22. India Transdermal Preparation Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Transdermal Preparation by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transdermal Preparation Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transdermal Preparation Markets in 2025
Figure 26. United States VS China: Transdermal Preparation Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Transdermal Preparation Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transdermal Preparation Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 30. China Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Transdermal Preparation Production Market Share 2025
Figure 32. World Transdermal Preparation Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Transdermal Preparation Production Value Market Share by Type in 2025
Figure 34. Injectable Preparations
Figure 35. Non Injectable Preparations
Figure 36. World Transdermal Preparation Production Market Share by Type (2021-2032)
Figure 37. World Transdermal Preparation Production Value Market Share by Type (2021-2032)
Figure 38. World Transdermal Preparation Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Transdermal Preparation Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 40. World Transdermal Preparation Production Value Market Share by Dosage Form in 2025
Figure 41. Patch
Figure 42. Cataplasm Hydrogel Patch
Figure 43. Hot Melt Adhesive Patch
Figure 44. Other
Figure 45. World Transdermal Preparation Production Market Share by Dosage Form (2021-2032)
Figure 46. World Transdermal Preparation Production Value Market Share by Dosage Form (2021-2032)
Figure 47. World Transdermal Preparation Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 48. ? 12.5 ?g/h
Figure 49. 12.5 ? 25 ?g/h
Figure 50. 25 ? 50 ?g/h
Figure 51. 50 ? 100 ?g/h
Figure 52. ? 100 ?g/h
Figure 53. World Transdermal Preparation Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Transdermal Preparation Production Value Market Share by Application in 2025
Figure 55. Hospital
Figure 56. Clinic
Figure 57. Other
Figure 58. World Transdermal Preparation Production Market Share by Application (2021-2032)
Figure 59. World Transdermal Preparation Production Value Market Share by Application (2021-2032)
Figure 60. World Transdermal Preparation Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. Transdermal Preparation Industry Chain
Figure 62. Transdermal Preparation Procurement Model
Figure 63. Transdermal Preparation Sales Model
Figure 64. Transdermal Preparation Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
